High-quality transurethral bladder tumor resection including underlying muscle fibers is of
utmost importance. Nevertheless, tumor understaging remains an issue of concern and …

Muscle-invasive bladder cancer is a deadly disease that often requires more than radical
surgery for optimal management. The best level one evidence supports the use of …

Background Bladder-sparing chemoradiation therapy is a definitive first-line treatment option
for muscle-invasive bladder cancer. Randomized trials have demonstrated that the addition …

Background Outcomes of neoadjuvant chemotherapy in patients with muscle-invasive
urothelial bladder carcinoma (MIUBC) should be improved. Sorafenib was combined with …

Background The recommended treatment for patients with non-metastatic muscle-invasive
bladder cancer (MIBC) is neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) …

Purpose: We assessed survival dependent on pathological response after neoadjuvant
chemotherapy in a large multicenter patient cohort, with a particular focus on the difference …

Background The purpose of this study was to evaluate the effect of neoadjuvant
chemotherapy (NACT) on squamous variant (SV) bladder cancer by investigating patients …

Many patients diagnosed with muscle-invasive bladder cancer (MIBC) will develop distant
metastatic disease. Over the past three decades, perioperative cisplatin-based …

Materials and Methods: We performed a retrospective analysis of patients who underwent
RC between 1992 and 2011. NAC was advised for patients with clinical stage≥ T2 …

METHODS We reviewed our institutional review board approved database to identify
patients with MIBC who underwent NC followed by RC from March 2003 to August 2016 …